Homepage
IMI impact on patient involvement - Event
This event is part of a series of live sessions that IMI is organising on IMI Impacts, where key actors will explore the key challenges in their respective fields and demonstrate how IMI contributed.
Clinical trials for infectious disease research, on demand
Clinical trials for infectious disease research, on demand moreNew non-profit organisation to help usher in EU’s networked and harmonised health data space
New non-profit organisation to help usher in EU’s networked and harmonised health data space moreFrom relevance to readability: using well-defined ‘personas’ to improve the patient information journey
From relevance to readability: using well-defined ‘personas’ to improve the patient information journey more
IMI – radical collaboration in action
A new brochure, 'IMI - radical collaboration in action', showcases some recent IMI project successes, which include an approved vaccine for Ebola, insights into the genetics of Alzheimer’s disease, a new classification of diabetes, and advances on using liquid biopsies for cancer, as well as contributions to the fight against COVID-19.
IMI covid-19 response
Within weeks of the first reports of coronavirus in Europe, IMI launched a fast-track Call for proposals to develop therapeutics and diagnostics for current and future coronavirus outbreaks